Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly


Aydin K., Aydin C., Dagdelen S., Tezel G. G., Erbas T.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.124, sa.3, ss.198-202, 2016 (SCI-Expanded) identifier identifier identifier

Özet

Aim: Acromegaly is associated with increased thyroid cancer risk. We aimed to analyze the frequency of point mutations of BRAF and RAS genes, and RET/PTC, PAX8/PPAR gamma gene rearrangements in patients with acromegaly having differentiated thyroid cancers (DTC) and their relation with clinical and histological features.